Judge denies dismissal of Nexium pay-for-delay suit, trims some state-law claims
Purchasers may move forward with their claims that they are being injured by a pay-for-delay agreement involving AstraZeneca’s acid reflux drug Nexium, a Massachusetts federal judge said.Purchasers may move forward with their claims...To view the full article, register now.
Already a subscriber? Click here to view full article